Home Compliance Did the Company Violate FCA By Promoting an Off-Label Use of Botox?... ComplianceFCAResource Library Did the Company Violate FCA By Promoting an Off-Label Use of Botox? The Court Did Not Think So March 24, 2025 28 CrizzyStudio | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Relator Alleged the Government Could Not Intervene Due to Conflict of Interest. Why Did the Court Dismiss the Case? Compliance False Claims Act Insights – DOJ’s Reliance on FCA to Pursue Covid-Related Fraud Cyber Cybersecurity Failures Lead to False Claims Act Case Against Government Contractor
